2-207269271-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000412387.5(MYOSLID-AS1):​n.316-28933A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.189 in 532,310 control chromosomes in the GnomAD database, including 12,340 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.24 ( 6030 hom., cov: 32)
Exomes 𝑓: 0.17 ( 6310 hom. )

Consequence

MYOSLID-AS1
ENST00000412387.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.89

Publications

12 publications found
Variant links:
Genes affected
LINC01802 (HGNC:52591): (long intergenic non-protein coding RNA 1802)
MIR1302-4 (HGNC:35296): (microRNA 1302-4) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.46 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LINC01802NR_146973.1 linkn.316+378T>C intron_variant Intron 2 of 2
MIR1302-4NR_031633.1 linkn.*4A>G downstream_gene_variant
MIR1302-4unassigned_transcript_534 n.*57A>G downstream_gene_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MYOSLID-AS1ENST00000412387.5 linkn.316-28933A>G intron_variant Intron 4 of 4 4
MYOSLID-AS1ENST00000432413.3 linkn.298-15016A>G intron_variant Intron 4 of 5 3
LINC01802ENST00000438824.2 linkn.750+378T>C intron_variant Intron 3 of 3 3

Frequencies

GnomAD3 genomes
AF:
0.239
AC:
36291
AN:
152036
Hom.:
6022
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.466
Gnomad AMI
AF:
0.171
Gnomad AMR
AF:
0.196
Gnomad ASJ
AF:
0.139
Gnomad EAS
AF:
0.176
Gnomad SAS
AF:
0.199
Gnomad FIN
AF:
0.0943
Gnomad MID
AF:
0.168
Gnomad NFE
AF:
0.147
Gnomad OTH
AF:
0.214
GnomAD2 exomes
AF:
0.180
AC:
44292
AN:
245688
AF XY:
0.174
show subpopulations
Gnomad AFR exome
AF:
0.472
Gnomad AMR exome
AF:
0.227
Gnomad ASJ exome
AF:
0.148
Gnomad EAS exome
AF:
0.163
Gnomad FIN exome
AF:
0.0891
Gnomad NFE exome
AF:
0.145
Gnomad OTH exome
AF:
0.160
GnomAD4 exome
AF:
0.169
AC:
64388
AN:
380156
Hom.:
6310
Cov.:
0
AF XY:
0.168
AC XY:
36337
AN XY:
216576
show subpopulations
African (AFR)
AF:
0.472
AC:
4914
AN:
10422
American (AMR)
AF:
0.227
AC:
8228
AN:
36274
Ashkenazi Jewish (ASJ)
AF:
0.147
AC:
1721
AN:
11738
East Asian (EAS)
AF:
0.172
AC:
2262
AN:
13166
South Asian (SAS)
AF:
0.196
AC:
13071
AN:
66642
European-Finnish (FIN)
AF:
0.0961
AC:
3106
AN:
32316
Middle Eastern (MID)
AF:
0.162
AC:
199
AN:
1230
European-Non Finnish (NFE)
AF:
0.147
AC:
28135
AN:
191840
Other (OTH)
AF:
0.167
AC:
2752
AN:
16528
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.461
Heterozygous variant carriers
0
2976
5952
8929
11905
14881
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
376
752
1128
1504
1880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.239
AC:
36335
AN:
152154
Hom.:
6030
Cov.:
32
AF XY:
0.235
AC XY:
17464
AN XY:
74380
show subpopulations
African (AFR)
AF:
0.466
AC:
19308
AN:
41462
American (AMR)
AF:
0.196
AC:
2998
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.139
AC:
482
AN:
3468
East Asian (EAS)
AF:
0.176
AC:
910
AN:
5178
South Asian (SAS)
AF:
0.199
AC:
961
AN:
4820
European-Finnish (FIN)
AF:
0.0943
AC:
1000
AN:
10610
Middle Eastern (MID)
AF:
0.160
AC:
47
AN:
294
European-Non Finnish (NFE)
AF:
0.147
AC:
10025
AN:
68006
Other (OTH)
AF:
0.212
AC:
448
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1245
2489
3734
4978
6223
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
354
708
1062
1416
1770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.197
Hom.:
1984
Bravo
AF:
0.258
Asia WGS
AF:
0.189
AC:
659
AN:
3476

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.014
DANN
Benign
0.27
PhyloP100
-1.9

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10173558; hg19: chr2-208133995; COSMIC: COSV68660683; API